MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotyp
Go back to MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotyp| (NASDAQ: HYFT) | Delayed: 1.56 -0.08 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.64 | 52 Week High | $ | |||
| Open | $1.66 | 52 Week Low | $ | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.56 | EPS | $ | |||
| Volume | 271,490 | |||||
